Thursday, January 27, 2022

Anti-Covid drugs potent against Omicron, antibody therapies less effective: Study

The lab tests also showed that some antibodies have entirely lost their ability to neutralise Omicron at realistic dosages. "The bottom line is we have countermeasures to treat Omicron. That's good news," said study lead author Yoshihiro Kawaoka, from the University of Wisconsin-Madison in the US.

from Economic Times https://ift.tt/3fZ5msL

No comments:

Post a Comment

IREDA shares rise 1.1% as board announces meeting date for fund raise via QIP

IREDA shares rose by 1.1% to Rs 209.50 on news of a board meeting set for January 23, 2025, to approve fund-raising via Qualified Institutio...